These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results Terminated||2005-003436-21||A phase 2, multi-centre, randomised, double blind, placebo controlled study evaluating the efficacy, safety and pharmacokinetics of two doses of a candidate Disease Modifying Anti-Rheumatic Drug (DMAR...||2008-04-30||due-trials|
|Listed as ongoing, but also has a completion date and reported results||2006-003730-15||A 10-week randomised, double-blind, parallel-group, placebo-controlled phase 2 study to investigate the extent of symptom relief and the safety and tolerability of SMP-986 (20 mg, 40 mg, 80 mg and 120...||2008-06-05||bad-data|
|Ongoing, reported early||2007-003819-31||A Phase 3 Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of Three Doses of Lurasidone HCl in Acutely Psychotic Patients with Schizophrenia||not-yet-due|
|Completed, but no date, and reported results||2007-003820-40||A Phase 3 Randomized, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of Two Doses of Lurasidone HCl in Acutely Psychotic Patients with Schizophrenia||bad-data|
|Completed, but no date, and reported results||2008-003984-38||A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE COMPARATOR CONTROLLED CLINICAL TRIAL TO STUDY THE EFFICACY AND SAFETY OF TWO DOSES OF LURASIDONE IN ACUTELY PSYCHOTIC SUBJECTS WITH SCHIZOPHRENI...||bad-data|
|Listed as ongoing, but also has a completion date and reported results||2008-007457-13||A Randomized, 6-Week, Double-Blind, Placebo-controlled, Fixed-Flexible-Dose, Parallel-Group Study of Lurasidone in the Treatment of Bipolar I Depression||2012-02-14||bad-data|
|Listed as ongoing, but also has a completion date and reported results||2008-007482-23||A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel- Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression||2012-01-19||bad-data|
|Listed as ongoing, but also has a completion date and reported results||2008-007483-42||A 24-Week, Flexible-Dose, Open-label Extension Study of Lurasidone for the Treatment of Bipolar I Depression||2013-02-19||bad-data|
|Reported results||2009-012675-10||An exploratory, randomised, double blind, placebo controlled, 14 day, two-way crossover, inhaled allergen challenge study to evaluate the effects of SMP-028 in subjects with mild to moderate asthma||2010-06-11||due-trials|
|Listed as ongoing, but also has a completion date and reported results||2013-003038-34||A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of SM-13496 for the Treatment of Bipolar I Depression||2017-02-16||bad-data|
|Reported results||2013-003039-31||A Long-Term Study of SM-13496 in Patients with Bipolar I Disorder||2018-02-17||due-trials|
|Listed as ongoing, but also has a completion date||2016-004359-57||A Phase III Study of BBI-608 plus nab-Paclitaxel with Gemcitabine in Adult Patients with Metastatic Pancreatic Adenocarcinoma.||2020-03-29||bad-data|